More like next week.
I've held Lilly since 1995 ($15 per share!) for the divi and saw it run up like it has been once before.
It peaked at over $100 and split twice on the way.
If it did that again I'd have over 25,000 shares, would quit holding and be a very happy camper.
Only reason for them to do a reverse split would to get the pps above the magic $5 level where institutional buyers come in
Think it can reach the $5+ level just fine on it's own without splitting.
CTSO sure kicked but today. I bought CTSO and ADXS on the same day a few years ago, today was the day I had been waiting for. Going to keep holding both, believe there is still time left to get on the train for both.
Big pharma would just buy it up to hide on the back shelf, not enough to be made off it compared to drugs that go for $10,000 a treatment and kill the patent in the end.
If big pharma bought them out you you darn well know the products would be stashed away on the back shelf never to be seen again.
The treatment is too cheap and effective, they can't make all the money they do killing patents with chemo.
May not apply to you with a small amount but whenever I have a stock hit 100% I sell half.
This way you can't lose, only break even or win.
Two large nitrogen fertilizer plants are being built in the Bakken to utilize the excess NG.
Also read that many of the drill rigs are converting to diesel/NG combination engines to use the basically free fuel.
Have you looked at a recent satellite picture of the Bakken at night?
Middle of nowhere place is lit up like Chicago from all the drill rigs and NG flare stacks.
LLY Buying CYTR - Pretty Much Done Deal
This was posted on Sierra World Trading last night (Saturday - 12/14/13)......
Big Deal_Indianapolis Monday Meeting Between CytRx Corporation (CYTR) And Eli Lilly and Company (LLY) To Drive CytRx Shares Past $12 As Buyout Offer Hits The Table Ventures Sierra World Equity Review
HEADLINE: Big Deal_Indianapolis Monday Meeting Between CytRx Corporation (CYTR) And Eli Lilly and Company (LLY) To Drive CytRx Shares Past $12 As Buyout Offer Hits The Table Ventures Sierra World Equity Review.
CytRx Corporation (CYTR) And Eli Lilly and Company (LLY)
Thanks to all who were joined us for today's conference call as Sierra's team revealed their leads and insight they have garnished on the likely coming acquisition of CytRx by Eli Lilly. As revealed in the conference call the negotiations are presumably at an advanced level with close to final numbers being crunched by both parties. Sierra fully anticipates that the deal will now be done and announced within the next 2 months. Sierra forecasts that the share price of CYTR will quickly move up past $12 as big money and institutional buyingpours into the stock. Sierra will be replaying the conference call in it's entirety throughout the week on her site for those that missed it!
My bet is if you go to Vanguard's website and look a the fund's holdings you see one stock in common with both funds that really tanked today.
Maybe even went bankrupt.